MKDW vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

MKDW

37.9
AI Score
VS
EMR Wins

EMR

53.3
AI Score

Investment Advisor Scores

MKDW

38score
Recommendation
AVOID NEW MONEY

EMR

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MKDW EMR Winner
Forward P/E 0 23.3645 Tie
PEG Ratio 0 2.0511 Tie
Revenue Growth 12.9% 7.1% MKDW
Earnings Growth 0.0% 18.5% EMR
Tradestie Score 37.9/100 53.3/100 EMR
Profit Margin -92.6% 14.2% EMR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD EMR

Relative Price Performance (Last 90 Days)

MKDW 1M: -84.0% · 3M: -98.6% EMR 1M: +2.2% · 3M: +1.7%

Current Technical Phase

MKDW

Markdown
Sell / avoid

Price below a falling SMA50 (slope -63.0%), weak momentum, RSI 21

RSI (14): 21.4 · Price: $0.15

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.6% over 20 days), RSI 55

RSI (14): 55.2 · Price: $167.06

Fundamentals Snapshot

Metric MKDW EMR
Market Cap — —
Forward P/E 0.0 23.1
Trailing P/E — 35.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.5%
Operating Margin -4.1% 0.3%
EPS -1.69 4.79
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.